Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Daiichi Sankyo patents new phosphate transporter inhibitors

Nov. 12, 2014

PBI-4050 cleared to commence trials in patients with diabetic kidney disease

Nov. 12, 2014

Novel cystine derivatives inhibit stone formation in vivo

Nov. 7, 2014

Nymox's NX-1207 fails to achieve efficacy endpoints in phase III BPH trials

Nov. 3, 2014

Relypsa submits NDA to FDA seeking approval of patiromer for hyperkalemia

Oct. 23, 2014

Cardiotrophin-1 granted FDA orphan designation for use in kidney transplantation

Oct. 22, 2014

Fispemifene licensed to Apricus Biosciences

Oct. 21, 2014

Topline results reported from phase IIa study of LPCN-1111

Oct. 14, 2014

Patient enrollment under way in phase II trial of VPI-2690B in diabetic nephropathy

Oct. 9, 2014

Scientists at Roche synthesize novel autotaxin inhibitors

Oct. 9, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...